Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Endometrial Cancer: Is This a New Disease?

Moore K, Brewer MA.

Am Soc Clin Oncol Educ Book. 2017;37:435-442. doi: 10.14694/EDBK_175666. Review.

PMID:
28561715
2.

3D texture analysis for classification of second harmonic generation images of human ovarian cancer.

Wen B, Campbell KR, Tilbury K, Nadiarnykh O, Brewer MA, Patankar M, Singh V, Eliceiri KW, Campagnola PJ.

Sci Rep. 2016 Oct 21;6:35734. doi: 10.1038/srep35734.

3.

Coregistered photoacoustic and ultrasound imaging and classification of ovarian cancer: ex vivo and in vivo studies.

Salehi HS, Li H, Merkulov A, Kumavor PD, Vavadi H, Sanders M, Kueck A, Brewer MA, Zhu Q.

J Biomed Opt. 2016 Apr 30;21(4):46006. doi: 10.1117/1.JBO.21.4.046006.

4.

Texture analysis applied to second harmonic generation image data for ovarian cancer classification.

Wen BL, Brewer MA, Nadiarnykh O, Hocker J, Singh V, Mackie TR, Campagnola PJ.

J Biomed Opt. 2014 Sep;19(9):096007. doi: 10.1117/1.JBO.19.9.096007.

5.

Ovarian Cancer Cell Adhesion/Migration Dynamics on Micro-Structured Laminin Gradients Fabricated by Multiphoton Excited Photochemistry.

He RY, Ajeti V, Chen SJ, Brewer MA, Campagnola PJ.

Bioengineering (Basel). 2015 Jul 16;2(3):139-159. doi: 10.3390/bioengineering2030139.

6.

Intrapericardial delivery of amiodarone rapidly achieves therapeutic levels in the atrium.

Marcano J, Campos K, Rodriguez V, Handy K, Brewer MA, Cohn WE.

Heart Surg Forum. 2013 Oct;16(5):E279-86.

PMID:
24364084
7.

Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA.

Int J Oncol. 2013 Aug;43(2):495-502. doi: 10.3892/ijo.2013.1960. Epub 2013 May 24.

PMID:
23709006
8.

7,12-dimethylbenz[a]anthracene-induced malignancies in a mouse model of menopause.

Marion SL, Watson J, Sen N, Brewer MA, Barton JK, Hoyer PB.

Comp Med. 2013 Feb;63(1):6-12.

9.

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA.

Br J Cancer. 2013 Feb 19;108(3):579-86. doi: 10.1038/bjc.2013.10. Epub 2013 Jan 31.

10.

Two-photon excited fluorescence imaging of endogenous contrast in a mouse model of ovarian cancer.

Watson JM, Marion SL, Rice PF, Utzinger U, Brewer MA, Hoyer PB, Barton JK.

Lasers Surg Med. 2013 Mar;45(3):155-66. doi: 10.1002/lsm.22115. Epub 2013 Jan 29.

11.

Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma.

Watson JM, Rice PF, Marion SL, Brewer MA, Davis JR, Rodriguez JJ, Utzinger U, Hoyer PB, Barton JK.

J Biomed Opt. 2012 Jul;17(7):076002. doi: 10.1117/1.JBO.17.7.076002.

12.

Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic.

George R, Michaelides M, Brewer MA, Utzinger U.

Lasers Surg Med. 2012 Apr;44(4):282-95. doi: 10.1002/lsm.22014. Epub 2012 Mar 7.

PMID:
22407572
13.

Simultaneous optical coherence tomography and laser induced fluorescence imaging in rat model of ovarian carcinogenesis.

Hariri LP, Liebmann ER, Marion SL, Hoyer PB, Davis JR, Brewer MA, Barton JK.

Cancer Biol Ther. 2010 Sep 1;10(5):438-47.

14.

Clinical research device for ovarian cancer detection by optical spectroscopy in the ultraviolet C-visible.

George R, Chandrasekaran A, Brewer MA, Hatch KD, Utzinger U.

J Biomed Opt. 2010 Sep-Oct;15(5):057009. doi: 10.1117/1.3503468.

15.

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.

Chambers SK, Clouser MC, Baker AF, Roe DJ, Cui H, Brewer MA, Hatch KD, Gordon MS, Janicek MF, Isaacs JD, Gordon AN, Nagle RB, Wright HM, Cohen JL, Alberts DS.

Clin Cancer Res. 2010 Nov 1;16(21):5320-8. doi: 10.1158/1078-0432.CCR-10-0974.

16.

Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.

Nadiarnykh O, LaComb RB, Brewer MA, Campagnola PJ.

BMC Cancer. 2010 Mar 11;10:94. doi: 10.1186/1471-2407-10-94.

17.

Adhesion and migration of ovarian cancer cells on crosslinked laminin fibers nanofabricated by multiphoton excited photochemistry.

Chen X, Brewer MA, Zou C, Campagnola PJ.

Integr Biol (Camb). 2009 Jul;1(7):469-76. doi: 10.1039/b906310b. Epub 2009 Jun 11.

18.

The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.

Khalil I, Brewer MA, Neyarapally T, Runowicz CD.

Gynecol Oncol. 2010 Feb;116(2):282-5. doi: 10.1016/j.ygyno.2009.10.085. Review.

PMID:
19931138
19.

Laparoscopic optical coherence tomography imaging of human ovarian cancer.

Hariri LP, Bonnema GT, Schmidt K, Winkler AM, Korde V, Hatch KD, Davis JR, Brewer MA, Barton JK.

Gynecol Oncol. 2009 Aug;114(2):188-94. doi: 10.1016/j.ygyno.2009.05.014. Epub 2009 May 29.

20.

A collaborative approach to building the capacity for research and evidence-based practice in community hospitals.

Brewer BB, Brewer MA, Schultz AA.

Nurs Clin North Am. 2009 Mar;44(1):11-25, ix. doi: 10.1016/j.cnur.2008.10.003. Review.

PMID:
19167545
21.

Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.

Hoyer PB, Davis JR, Bedrnicek JB, Marion SL, Christian PJ, Barton JK, Brewer MA.

Gynecol Oncol. 2009 Mar;112(3):610-5. doi: 10.1016/j.ygyno.2008.12.013. Epub 2009 Jan 16.

22.

Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Munir SM, Bogaev RC, Sobash E, Shankar KJ, Gondi S, Stupin IV, Robertson J, Brewer MA, Casscells SW, Delgado RM, Ahmed A.

Tex Heart Inst J. 2008;35(2):166-73. Review.

23.

Computer-aided identification of ovarian cancer in confocal microendoscope images.

Srivastava S, Rodríguez JJ, Rouse AR, Brewer MA, Gmitro AF.

J Biomed Opt. 2008 Mar-Apr;13(2):024021. doi: 10.1117/1.2907167.

24.

Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy.

Kirkpatrick ND, Brewer MA, Utzinger U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2048-57.

25.

Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.

Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E.

Clin Exp Immunol. 2007 Apr;148(1):136-45.

26.

Guidelines for referral of the patient with an adnexal mass.

Gostout BS, Brewer MA.

Clin Obstet Gynecol. 2006 Sep;49(3):448-58. Review.

PMID:
16885652
27.

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK; AACR Task Force on Cancer Prevention.

Clin Cancer Res. 2006 Jun 15;12(12):3661-97. Review.

28.

Retrospective analysis of 286 patients requiring circulatory support with the intraaortic balloon pump. 1977.

Johnson MD, Holub DA, Winston DS, Brewer MA, Hibbs CW, Leachman CJ, Norman JC.

Tex Heart Inst J. 2005;32(1):61-9; discussion 60. No abstract available.

29.

Exploratory study of ovarian intraepithelial neoplasia.

Brewer MA, Ranger-Moore J, Baruche A, Alberts DS, Greene M, Thompson D, Liu Y, Davis J, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):299-305.

30.

Imaging of the ovary.

Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, Stevens SJ, Gmitro AF.

Technol Cancer Res Treat. 2004 Dec;3(6):617-27.

PMID:
15560720
31.

Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring.

Kirkpatrick ND, Zou C, Brewer MA, Brands WR, Drezek RA, Utzinger U.

Photochem Photobiol. 2005 Jan-Feb;81(1):125-34.

PMID:
15535738
32.

Preneoplastic changes in ovarian tissues.

Brewer MA, Ranger-Moore J, Greene MH, Alberts DS, Liu Y, Bartels HG, Baruch AC, Bartels PH.

Anal Quant Cytol Histol. 2004 Aug;26(4):207-16.

PMID:
15457673
33.

Optical imaging of the cervix.

Drezek RA, Richards-Kortum R, Brewer MA, Feld MS, Pitris C, Ferenczy A, Faupel ML, Follen M.

Cancer. 2003 Nov 1;98(9 Suppl):2015-27. Review.

34.

Specific keynote: chemoprevention of ovarian cancer: the journey begins.

Ozols RF, Daly MB, Klein-Szanto A, Hamilton TC, Bast RC Jr, Brewer MA.

Gynecol Oncol. 2003 Jan;88(1 Pt 2):S59-66; discussion S67-70. Review. No abstract available.

PMID:
12586088
35.

Prevention of ovarian cancer: intraepithelial neoplasia.

Brewer MA, Johnson K, Follen M, Gershenson D, Bast R Jr.

Clin Cancer Res. 2003 Jan;9(1):20-30. Review.

36.

Metastatic uterine papillary serous carcinoma to the pericardium.

Ramirez PT, Ramondetta LM, Burke TW, Gershenson DM, Brewer MA.

Gynecol Oncol. 2001 Oct;83(1):135-7.

PMID:
11585425
37.

Prevention of ovarian cancer.

Brewer MA, Mitchell MF, Bast RC.

In Vivo. 1999 Jan-Feb;13(1):99-106. Review.

PMID:
10218141
38.

Prevalence of tremor and Parkinson's disease.

Khatter AS, Kurth MC, Brewer MA, Crinnian CT, Drazkowski JF, Flitman SS, Imke S, Spector SA, Wood KL, Lieberman AN.

Parkinsonism Relat Disord. 1996 Oct;2(4):205-8.

PMID:
18591041
39.

Enzyme conversion of lignocellulosic plant materials for resource recovery in a Controlled Ecological Life Support System.

Kohlmann KL, Westgate P, Velayudhan A, Weil J, Sarikaya A, Brewer MA, Hendrickson RL, Ladisch MR.

Adv Space Res. 1996;18(1-2):251-65.

PMID:
11538970
40.

Who should receive hepatitis A vaccine?

Brewer MA, Edwards KM, Decker MD.

Pediatr Infect Dis J. 1995 Apr;14(4):258-60. No abstract available.

PMID:
7603804
41.

Bacille Calmette-Guérin immunization in normal healthy adults.

Brewer MA, Edwards KM, Palmer PS, Hinson HP.

J Infect Dis. 1994 Aug;170(2):476-9.

PMID:
8035041
42.

Controlled study of the antiparkinsonian activity and tolerability of cabergoline.

Hutton JT, Morris JL, Brewer MA.

Neurology. 1993 Mar;43(3 Pt 1):613-6.

PMID:
8451010
43.
44.

The hemodynamics of arterial steal.

Hyman WA, Brewer MA.

J Biomech. 1980;13(6):469-75. No abstract available.

PMID:
7400175
46.

Intra-aortic balloon pumping: theory and practice. Experience with 325 patients.

Igo SR, Hibbs CW, Trono R, Fuqua JM, Edmonds CH, Leachman CJ, Brewer MA, Holub DA, Norman JC.

Artif Organs. 1978 Aug;2(3):249-56.

PMID:
708286
47.

Molecular, microscopic, microstructural and mechanical methods of analyzing pseudoneointimal linings within partial artificial hearts in man and the calf.

Trono R, Brewer MA, Edmonds CH, Fuqua JM, Hibbs CW, Holub DA, Igo SR, Norman JC.

Artif Organs. 1978 May;2(2):173-82.

PMID:
687175
48.

Quantitative methods for testing pseudoneointima developing on textured blood-interfacing surfaces within left ventricular assist devices (LVADS).

Trono R, Hibbs CW, Fuqua JM, Edmonds CH, Holub DA, Brewer MA, Igo SR, Norman JC.

Trans Am Soc Artif Intern Organs. 1978;24:352-6. No abstract available.

PMID:
716024
49.

Algorithm for evaluation of postcardiotomy or infarction low output syndromes during mechanical circulatory support (IABP/ALVAD).

Brewer MA, Igo SR, Holub DA, Hibbs CW, Fuqua JM, Edmonds CH, Trono R, Norman JC.

Trans Am Soc Artif Intern Organs. 1978;24:288-97. No abstract available.

PMID:
716013
50.

RETROSPECTIVE ANALYSIS OF 286 PATIENTS REQUIRING CIRCULATORY SUPPORT WITH THE INTRAAORTIC BALLOON PUMP.

Johnson MD, Holub DA, Winston DS, Brewer MA, Hibbs CW, Leachman CJ, Norman JC.

Cardiovasc Dis. 1977;4(4):428-436. No abstract available.

Supplemental Content

Loading ...
Support Center